[1]Patent:US2018/186818,2018,A1
[1]Patent:US2018/186818,2018,A1.Locationinpatent:Paragraph0928;0929
[1]Patent:US2021/47294,2021,A1.Locationinpatent:Paragraph0976-0977
114312-57-1
13671-00-6
14659-60-0
174403-69-1
175278-29-2
18355-74-3
851266-74-5 | 6-(4-(Trifluoromethoxy)phenyl)nicotinic acid | AA00G2RR | MFCD06410408
66067-06-9 | 1H-Pyrrole-2-carboxylic acid, 4,5-dibromo-1-methyl- | AA00H8JD | MFCD09863354
76360-42-4 | Methyl 2-chlorothiophene-3-carboxylate | AA00ICNM | MFCD14698135
945668-94-0 | 11,11'-(Piperazine-1,4-diyl)bis(dibenzo[b,f][1,4]thiazepine) | AA00JNYM | MFCD19705149
627902-36-7 | 2-[(2-methoxyethyl)sulfanyl]acetic acid | AA019LXN | MFCD09971671
54495-51-1 | (E)-3-(Pyridin-2-yl)acrylic acid | AA019UOZ | MFCD00179422
1696838-10-4 | 1-(propan-2-yl)-1H-pyrazole-3-sulfonamide | AA01B3SP | MFCD30329853
1300640-25-8 | 5-[4-(Chloromethyl)phenyl]-2-ethoxypyridine | AA01D8MI | MFCD30183462
1628776-32-8 | 3,5-Diiodo-L-thyronine4’-O-Sulfate | AA01E2H3
1840942-14-4 | N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl-d7]-octadecanamide | AA01EPSU
130674-54-3
677706-82-0
297137-85-0
243454-98-0